and/or

935 Blog posts found

In the Clinic

FDA Approves “Game Changer” Immunotherapy Drug for Bladder Cancer

The FDA approved the immunotherapy drug atezolizumab for people with metastatic urothelial bladder cancer, the first new treatment for this form of the disease in more than 20 years.

Bladder cancer survivor and his wife on a sailboat.

Feature

The Future of Cancer Research: Five Reasons for Optimism

Discover some of the most exciting research that Memorial Sloan Kettering scientists are pursuing in the fight against cancer.

DNA molecules wrapped around histones

In the Clinic

Robot-Assisted Surgery at MSK Helps a Growing Number of Patients

MSK performs the highest number of robot-assisted surgeries in the United States, enabling more patients to have a shorter hospital stay and a faster recovery.

A man standing with his wife and three sons.

Feature

Is Chemo Brain Real?

Cancer treatments like chemotherapy may cause cognitive changes, which experts call “chemo brain.” Learn how Memorial Sloan Kettering experts help patients with this condition.

author finds help for chemo brain

Feature

6 Myths about Testicular Cancer

Separate fact from fiction regarding testicular cancer.

Man examining himself.

In the Clinic

When Heartburn Signals Cancer Risk

Many people don’t know that gastroesophageal reflux disease (GERD) is a potentially serious condition that — if left untreated — can ultimately lead to esophageal cancer.

Older man talking with a doctor.

In the News

At #AACR16, Vice President Biden Unveils ‘Moonshot’ Goal: A Decade’s Worth of Progress in Five Years

The 2016 annual meeting of the American Association for Cancer Research (AACR) ended with a visit from the Vice President.

Announcement

News from #AACR16: Precision Medicine Progress, Turbocharged CARs, and Turning Up the Heat against Cancer

At the 2016 American Association for Cancer Research (AACR) conference, there were clear signs that cancer treatment is evolving from a slash-and-burn method to a more precisely targeted, intelligent approach.

José Baselga

Announcement

News from #AACR16: Targeted Therapy Breakthrough, Improved Survival in Melanoma, and Benefits of Gut Bugs

Long-awaited results of clinical trials testing targeted drugs and immunotherapy combinations were on offer at the annual American Association for Cancer Research (AACR) conference.

Dr. Joan Massagué, Sloan Kettering Institute Director received the Pezcoller Foundation-AACR International Award for Cancer Research and was named an AACR fellow at AACR16.

Announcement

MSK Is Named Founding Member of Parker Institute for Cancer Immunotherapy

Cancer immunotherapy got a big boost today in the form of a $250 million grant from the Parker Foundation and a new brain trust composed of the world’s top scientists.

Sean Parker